Matwings

About Matwings

Matwings Technology is a global leader in AI protein design, focusing on enzyme modification and drug protein design. The company aims to empower clients by improving product performance, shortening R&D cycles, reducing manufacturing costs, and building patent barriers.

Products & Services

AI Protein Design:Utilizes AI to design proteins, with expertise in enzyme modification and drug protein design, having learned from nearly 9 billion protein sequence data and delivered over 30 industrial projects.

AI + Enzyme Catalysis:Combines AI technology with enzyme catalysis for innovative solutions.

AI + Biopharmaceuticals:Applies AI to biopharmaceutical development for enhanced drug design.

Applications:Covers a wide range of applications including antibodies, nutrition, vaccines, food & drink, in vitro diagnostics (IVD), beauty, cell therapy, washing textiles, gene therapy, bioenergy, active pharmaceutical ingredients (API), and biological agriculture.

Specialties

AI Protein Design Enzyme Modification Drug Protein Design Enzyme Catalysis Biopharmaceuticals

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 10000000 MR: - FA: tens of millions USD FAN: 10000000	D: 2024-12-25 FD: 2024-12-25	1 investors

Series A Latest

2024-12-25

$10.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

刘

刘灏

Chief Technology Officer

Recent News

Matwings Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised